Skip to content
TNYA·Nasdaq·US

Tenaya Therapeutics

Tenaya Therapeutics is a clinical-stage biotechnology company focused on developing genetic medicines for cardiovascular disease. Its pipeline includes AAV-based gene therapies for inherited cardiomyopathies, alongside small-molecule programs and internally developed capabilities in capsid engineering, disease modeling, and manufacturing.

Thematic Position

Relationship Groups

Competitors2

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.